Wogonin but not Nor-wogonin inhibits lipopolysaccharide and lipoteichoic acid-induced iNOS gene expression and NO production in macrophages

International Immunopharmacology

Volumn 7, Issue 8, 2007, Pages 1054-1063

  Huang, Guan Cheng ^a   Chow, Jyh Ming ^b   Shen, Shing Chuan ^b   Yang, Liang Yo ^c   Lin, Cheng Wei ^c   Chen, Yen Chou ^c  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

iNOS; JNKs; LPS; LTA; NO; Nor wogonin; Wogonin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 7 HYDROXYFLAVONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CHRYSIN; FLAVONE DERIVATIVE; FLAVONOID; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; NORWOGONIN; PRIMULETIN; PROTEIN C FOS; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; WOGONIN;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; GENE EXPRESSION; GENE REPRESSION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTHRACENES; BLOTTING, WESTERN; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVANONES; FLAVONES; FLAVONOIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INHIBITORY CONCENTRATION 50; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MOLECULAR STRUCTURE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-JUN; QUERCETIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCUTELLARIA BAICALENSIS; TEICHOIC ACIDS;

EID: 34249991792     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.04.001     Document Type: Article

References (29)

1. Middleton Jr. E., Kandaswami C., and Theoharis C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52 (2000) 673-751
2. Duval D.L., Miller D.R., Collier J., and Billings R.E. Characterization of hepatic nitric oxide synthase: identification as the cytokine-inducible form primarily regulated by oxidants. Mol Pharmacol 50 (1996) 277-284
3. Marletta M.A. Nitric oxide synthase structure and mechanism. J Biol Chem 268 (1993) 12231-12234
4. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 6 (1992) 3051-3064
5. Chang Y.C., Li P.C., Chen B.C., Chang M.S., Wang J.L., Chiu W.T., et al. Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-kappaB pathways. Cell Signal 18 (2006) 1235-1243
6. Jiang W., and Pisetsky D.S. The role of IFN-alpha and nitric oxide in the release of HMGB1 by RAW 264.7 cells stimulated with polyinosinic-polycytidylic acid or lipopolysaccharide. J Immunol 177 (2006) 3337-3343
7. 2 induced liver injury. Eur J Pharmacol 536 (2006) 192-199
8. Bonham M., Posakony J., Coleman I., Montgomery B., Simon J., and Nelson P.S. Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma. Clin Cancer Res 11 (2005) 3905-3914
9. Park S., Hahm K.B., Oh T.Y., Jin J.H., and Choue R. Preventive effect of the flavonoid, wogonin, against ethanol-induced gastric mucosal damage in rats. Dig Dis Sci 49 (2004) 384-394
10. Chen Y.C., Shen S.C., Chen L.G., Lee T.J.F., and Yang L.L. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase 2 gene expressions induced by NOS inhibitors and lipopolysaccharide. Biochem Pharmacol 61 (2001) 1417-1427
11. 2 productions. Eur J Pharmacol 446 (2002) 187-194
12. Shen S.C., Lin C.W., Lee H.M., Chien L.L., and Chen Y.C. LPS plus TPA induction of migration and invasion of glioma cells in vitro and in vivo: differential inhibitory effects of flavonoids. Neuroscience 140 (2006) 477-489
13. Lin H.Y., Shen S.C., and Chen Y.C. Anti-inflammatory effect of heme oxygenase 1: glycosylation and nitric oxide inhibition in macrophages. J Cell Physiol 202 (2005) 579-590
14. Ko C.H., Shen S.C., Lee T.J.F., and Chen Y.C. Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol Cancer Ther 4 (2005) 281-290
15. Wu H.H., Hsieh W.S., Yang Y.Y., and Tsai M.C. Lipoteichoic acid induces prostaglandin E(2) release and cyclooxygenase-2 synthesis in rat cortical neuronal cells: involvement of PKCepsilon and ERK activation. Life Sci 79 (2006) 272-280
16. Han S.H., Kim J.H., Seo H.S., Martin M.H., Chung G.H., Michalek S.M., et al. Lipoteichoic acid-induced nitric oxide production depends on the activation of platelet-activating factor receptor and Jak2. J Immunol 176 (2006) 573-579
17. Jung S.W., Lee M.H., Kim Y.C., Paik S.G., Choi Y.H., Kim Y.S., et al. Modulation of the transactivation function of nuclear factor-kappaB by lipopolysaccharide in RAW264.7 macrophages. Int J Oncol 25 (2004) 1081-1087
18. Kim J.H., Kim D.H., Baek S.H., Lee H.J., Kim M.R., Kwon H.J., et al. Rengyolone inhibits inducible nitric oxide synthase expression and nitric oxide production by down-regulation of NF-kappaB and p38 MAP kinase activity in LPS-stimulated RAW 264.7 cells. Biochem Pharmacol 71 (2006) 1198-1205
19. Noroozi M., Angerson W.J., and Lean M.E. Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am J Clin Nutr 67 (1998) 1210-1218
20. Silva M.M., Santos M.R., Caroco G., Rocha R., Justino G., and Mira L. Structure-antioxidant activity relationships of flavonoids: a re-examination. Free Radic Res 36 (2002) 1219-1227
21. Rosenkranz H.S., and Thampatty B.P. SAR: flavonoids and COX-2 inhibition. Oncol Res 13 (2003) 529-535
22. 2 production. Int J Cancer 108 (2004) 502-510
23. Ko C.H., Shen S.C., and Chen Y.C. Hydroxylation at c4′ or c6 is essential for apoptosis-inducing activity of flavanone through activation of the caspase 3 cascade and production of reactive oxygen species. Free Radic Biol Med 36 (2004) 897-910
24. Yu C.S., Yu F.S., Chuang Y.C., Lu H.F., Lin S.Y., Chiu T.H., et al. Wogonin inhibits N-acetyltransferase activity and gene expression in human leukemia HL-60 cells. Anticancer Res 25 (2005) 127-132
25. Lin C.M., Chang H., Chen Y.H., Li S.Y., Wu I.H., and Chiu J.H. Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1. Int Immunopharmacol 6 (2006) 1690-1698
26. Fas S.C., Baumann S., Zhu J.Y., Giaisi M., Treiber M.K., Mahlknecht U., et al. Wogonin sensitizes resistant malignant cells to TNFalpha- and TRAIL-induced apoptosis. Blood 108 (2006) 3700-3706
27. Chen T.J., Shen S.C., Lin H.Y., Chien L.L., and Chen Y.C. Lipopolysaccharide enhancement of 12-ï-tetradecanoylphorbol 13-acetate-mediated transformation in rat glioma C6, accompanied by induction of inducible nitric oxide synthase. Toxicol Lett 147 (2004) 1-13
28. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci U S A 101 (2004) 4003-4008
29. Miyoshi T., Li Y., Shih D.M., Wang X., Laubach V.E., Matsumoto A.H., et al. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice. Life Sci 79 (2006) 525-531